New combo attack on tough sarcomas before surgery
NCT ID NCT06128863
Summary
This study is testing a new treatment approach for patients with certain soft tissue sarcomas. Before surgery, patients receive a combination of two immunotherapy drugs and a course of radiation therapy. The main goal is to see how much of the tumor is killed by this pre-surgery treatment and to monitor patient safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Maria Sklodowska-Curie National Research Institute of Oncology
Warsaw, 00-738, Poland
Conditions
Explore the condition pages connected to this study.